Related Experiment Video
Updated: Aug 10, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Advances in Polysaccharide-Based Oral Colon-Targeted Delivery Systems: The Journey So Far and the Road Ahead
1Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Abstract:
Various colon-targeted oral delivery systems have been explored so far to treat colorectal diseases, including timed-release systems, prodrugs, pH-based polymer coatings, and microflora-triggered systems. Among them, the microbially triggered system has gained attention. Among various oral colon-targeted delivery systems discussed, the polysaccharide-based colon-targeted delivery system has been found to be quite promising as polysaccharides remain unaffected by gastric as well as upper intestine milieu and are only digested by colonic bacteria upon reaching the colon. The major bottleneck associated with this delivery is that non-suitability of this system during the diseased state due to decrease in bacterial count at that time. This causes the failure of delivery system to release the drug even at colonic site as the polysaccharide matrix/coat cannot be digested properly due to lack of bacteria. The co-administration of probiotics is reported to compensate for the bacterial loss besides facilitating site-specific release. However, this research is also limited at the preclinical level. Hence, efforts are required to make this technology scalable and clinically applicable. This article entails in detail various oral colon-targeted delivery systems prepared so far, as well as the limitations and benefits of polysaccharide-based oral colon-targeted delivery systems.
Insights
Polysaccharide-based colon-targeted delivery systems offer promise for colorectal diseases. However, reduced bacterial counts during illness can hinder drug release, necessitating further research for clinical application.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Colorectal Therapeutics
Background:
- Oral colon-targeted delivery systems are crucial for treating colorectal diseases.
- Polysaccharide-based systems are promising due to selective colonic bacterial digestion.
- A key limitation is reduced bacterial count during disease, impairing drug release.
Purpose of the Study:
- To review various oral colon-targeted delivery systems.
- To detail the benefits and limitations of polysaccharide-based systems.
- To highlight challenges in clinical application and scalability.
Main Methods:
- Review of existing literature on colon-targeted drug delivery.
- Analysis of polysaccharide-based systems and their mechanisms.
- Discussion of factors affecting microflora-triggered systems.
Main Results:
- Polysaccharide systems are effective when colonic bacteria are abundant.
- Disease states can compromise the efficacy of these systems.
- Probiotic co-administration shows potential but requires further study.
Conclusions:
- Polysaccharide-based colon-targeted delivery systems require further development for clinical use.
- Addressing bacterial count reduction is critical for system reliability.
- Scalable and clinically applicable solutions are needed for widespread adoption.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...

